Medical specialists from China tagged as investigators in clinical trials studying Acute Myeloid Leukemia
Total 88 results
-
Aining Sun, M.D., Ph.D.Seen in:
- Jiangsu, Suzhou, The Fisrt Affiliated Hospital of Soochow University
Trials:- NCT02059720 (Sub-Investigator)
- NCT03919240 (Sub-Investigator)
-
Bei Liu, MDSeen in:
- Gansu, Lanzhou, The First Hospital of Lanzhou University
Trials:- NCT05042531 (Principal Investigator)
Conditions: -
Bin JiangSeen in:
- Beijing, Beijing, Peking University International Hospital
Trials:- NCT04202003 (Principal Investigator)
-
Bing XuSeen in:
- Fujian, Xiamen, Bing Xu
- Fujian, Xiamen, The First Affiliated hospital of Xiamen University
- Fujian, Xiamen, The First Affliliated Hospital of Xiamen University
- Guangdong, GuangZhou, Bing Xu
Trials:- NCT04837222 (Principal Investigator)
- NCT05305859 (Principal Investigator)
- NCT05603884 (Principal Investigator)
- NCT04202003 (Principal Investigator)
- NCT05979792 (Principal Investigator)
- NCT01889407 (Principal Investigator)
-
Chen XiaojuanSeen in:
- Tianjin, Tianjin, InstituteHBDH
Trials:- NCT03173612 (Principal Investigator)
- NCT06355739 (Principal Investigator)
-
Chen YumeiSeen in:
- Tianjin, Tianjin, InstituteHBDH
Trials:- NCT03173612 (Principal Investigator)
- NCT06355739 (Principal Investigator)
-
Chengcheng Fu, M.D., Ph.D.Seen in:
- Jiangsu, Suzhou, The Fisrt Affiliated Hospital of Soochow University
Trials:- NCT02059720 (Sub-Investigator)
- NCT03919240 (Sub-Investigator)
-
Chunyan JiSeen in:
- Shandong, Jinan, Qilu Hospital of Shandong University
- Shangdong, Jinan, Qilu Hospital of Shandong University
Trials:- NCT05924750 (Principal Investigator)
- NCT04202003 (Principal Investigator)
-
Daihong Liu, DoctorSeen in:
- Beijing, Beijing, Chinese PLA General Hospital
Trials:- NCT04284904 (Principal Investigator)
- NCT05088226 (Principal Investigator)
- NCT04778618 (Principal Investigator)
- NCT06068621 (Principal Investigator)
- NCT06084819 (Principal Investigator)
- NCT06119256 (Principal Investigator)
-
Depei Wu, MDSeen in:
- Jiangsu, Suzhou, The First Affiliated Hospital Of Soochow University
- Suzhou, The First Affiliated Hospital Of Soochow University
Trials:- NCT03256071 (Principal Investigator)
- NCT04260217 (Principal Investigator)
-
Fei Li, Ph.D.Seen in:
- Jiangxi, Nanchang, The First Affiliated Hospital of Nanchang University
Trials:- NCT04275518 (Principal Investigator)
-
Feng Chen, M.D., Ph.D.Seen in:
- Jiangsu, Suzhou, The Fisrt Affiliated Hospital of Soochow University
Trials:- NCT02059720 (Sub-Investigator)
- NCT03919240 (Sub-Investigator)
-
Guo YeSeen in:
- Tianjin, Tianjin, InstituteHBDH
Trials:- NCT03173612 (Principal Investigator)
- NCT06355739 (Principal Investigator)
-
Hailong HE, MDSeen in:
- Jiangsu, Suzhou, Children's Hospital of Soochow University
Trials:- NCT06221683 (Sub-Investigator)
Conditions: -
Haizhen MaSeen in:
- Gansu, Lanzhou, The First Hospital of Lanzhou University
Trials:- NCT05378971 (Sub-Investigator)
- NCT05042531 (Sub-Investigator)
Conditions: -
Hao ZhangSeen in:
- Gansu, Lanzhou, The First Hospital of Lanzhou University
Trials:- NCT05042531 (Sub-Investigator)
Conditions: -
He Huang, MDSeen in:
- Zhejiang, Hangzhou, The First Hospital of Zhejiang Medical Colleage Zhejiang University
- Zhejiang, Hangzhou, The first Affiliated Hospital, Zhejiang University School of Medicine
- Zhejiang, Hangzhou, The first affiliated hospital of medical college of zhejiang university
Trials:- NCT04226989 (Principal Investigator)
- NCT04227015 (Principal Investigator)
- NCT06118788 (Principal Investigator)
- NCT06120166 (Principal Investigator)
- NCT06235229 (Principal Investigator)
-
Heng Mei, M.D., Ph.DSeen in:
- Hubei, Wuhan, Union Hospital, Huazhong University of Science and Technology
- Hubei, Wuhan, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Hubei, Wuhan, Wuhan Union Hospital
Trials:- NCT04823091 (Principal Investigator)
- NCT05445011 (Principal Investigator)
- NCT04662099 (Principal Investigator)
- NCT05895994 (Principal Investigator)
- NCT05998928 (Principal Investigator)
- NCT06220097 (Principal Investigator)
Conditions:- T-Cell Lymphocytic Leukemia;
- T-Cell Chronic Lymphocytic Leukemia;
- T Cell Non-Hodgkin Lymphoma;
- Acute Myeloid Leukemia;
- CS1+ or BCMA+ Multiple Myeloma;
- Neoplasms;
- Neoplasms by Site;
- Hematologic Diseases;
- Hematologic Neoplasms;
- Multiple Myeloma;
- B-cell Acute Lymphoblastic Leukemia;
- B-cell Lymphoma Refractory
-
Hui Wei, M.D.Seen in:
- Tianjin, Tianjin, Hematology Hospital of the Chinese Academy of Medical Sciences
Trials:- NCT06389292 (Principal Investigator)
Conditions: -
Huiying Qiu, M.D., Ph.D.Seen in:
- Jiangsu, Suzhou, The Fisrt Affiliated Hospital of Soochow University
Trials:- NCT02059720 (Sub-Investigator)
- NCT03919240 (Sub-Investigator)
-
Jianxiang WangSeen in:
- Tianjin, Hospital of Blood Diseases, Chinese Academy of Medical Sciences
- Tianjin, Institute of Hematology & Blood Diseases Hospital
- Tianjin, Institute of Hematology & Blood Diseases Hospital of CAMS & PUMC
- Tianjin, Institute of Hematology and Hospital of Blood Disease, Chinese Academy of Medical Sciences
- Tianjin, Tianjin, Hematology Hospital of the Chinese Academy of Medical Sciences
- Tianjin, Tianjin, Hematology Hospital, Chinese Academy of Medical Sciences
- Tianjin, Tianjin, Hematology Hospital, Institute of Hematology, Chinese Academy of Medical Sciences
- Tianjin, Tianjin, Institute of Hematology & Blood Diseases Hospital
- Tianjin, Tianjin, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical
- Tianjin, Tianjin, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
- Tianjin, Tianjin, Institute of Hematology&Blood Diseases Hospital,Chinese Academy of Medical Sciences
Trials:- NCT02140606 (Principal Investigator)
- NCT03589326 (Principal Investigator)
- NCT04606433 (Principal Investigator)
- NCT05703204 (Principal Investigator)
- NCT05924750 (Principal Investigator)
- NCT06049667 (Principal Investigator)
- NCT04202003 (Principal Investigator)
- NCT05758610 (Principal Investigator)
- NCT05071482 (Principal Investigator)
- NCT05579132 (Principal Investigator)
- NCT04008524 (Principal Investigator)
- NCT05594784 (Principal Investigator)
- NCT05660473 (Principal Investigator)
- NCT05454241 (Principal Investigator)
- NCT05941585 (Principal Investigator)
- NCT05801835 (Principal Investigator)
Conditions:- Leukemia, Myeloid, Acute;
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL);
- Acute Lymphoblastic Leukemia;
- Non Hodgkin Lymphoma;
- Acute Myeloid Leukemia and Myelodysplastic Syndrome;
- Relapsed/Refractory Acute Myeloid Leukemia (R/R AML);
- Relapsed/Refractory Acute Myeloid Leukemia (AML);
- Acute Myeloid Leukemia (AML);
- Myelodysplastic Syndromes(MDS);
- AML, Adult Recurrent;
- NHL, Adult;
- Acute Leukemia;
- Relapsed and Refractory Hematological Malignancies;
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia;
- Precursor Cell Lymphoblastic Leukemia-Lymphoma;
- Hematological Malignancies;
- Acute Myeloid Leukemia
-
Jie Jin, M.D.Seen in:
- Zhejiang, Hangzhou, The First Affiliated Hospital of Zhejiang University School of Medicine
Trials:- NCT06389292 (Principal Investigator)
Conditions: -
Jie Li, MDSeen in:
- Jiangsu, Suzhou, Children's Hospital of Soochow University
Trials:- NCT06221683 (Sub-Investigator)
- NCT06316960 (Sub-Investigator)
-
Jingjing YeSeen in:
- Shangdong, Jinan, Qilu Hospital of Shandong University
Trials:- NCT05924750 (Principal Investigator)
Clinical Trials on Acute Myeloid Leukemia
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingSecondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Advesya SASNot yet recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryFrance, Sweden, Spain, Germany